Inferior Vena Cava Filters (IVCF) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: January 31, 2024 Report Code: GDME1705EPD-ST

Select Item

IVCF Pipeline Market Report Overview

An Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to the lungs. The filter is inserted inside a large vein called the inferior vena cava that carries blood from the lower extremities to the heart. IVC is commonly used as a preventive measure in cases where DVT and PE have been diagnosed or as a prophylactic device in cases where the risk of developing VTE is high and there is a contraindication for anticoagulants.

The IVCF pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Retrievable IVCF

·       Permanent IVCF

·       IVCF Retrieval Devices
Key Territories ·       The US

·       Europe

·       China

·       Global

·       New Zealand
Key Regulatory Paths ·       510(k)

·       CE

·       TGA

·       NMPA
Leading Companies ·       Adient Medical Inc.

·       APT Medical Inc

·       Contego Medical LLC

·       CyndRX LLC

·       Interventional & Surgical Innovations, LLC
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

IVCF Pipeline Market by Segments

The key segments in the IVCF pipeline market are Retrievable IVCF, Permanent IVCF, and IVCF Retrieval Devices. As of January 2024, Retrievable IVCF has the highest number of pipeline products. Retrievable IVCF can be retrieved or repositioned up to a certain point of time after insertion. They include both Optional Retrievable IVCF and Temporary Retrievable IVCF.

IVCF Pipeline Market Analysis by Segments, 2024 (%)
IVCF Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segment Insights into the IVCF Pipeline Market
Download a Free Report Sample

IVCF Pipeline Market Segmentation by Territories

A few of the key territories for IVCF pipeline products are the US, Europe, China, Global, and New Zealand. As of January 2024, the US accounted for the highest number of pipeline products.

IVCF Pipeline Market Analysis by Territories, 2024 (%)
IVCF Pipeline Market Analysis by Territories, 2024 (%)IVCF Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the IVCF Pipeline Market
Download a Free Report Sample

IVCF Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the IVCF pipeline market are 510(k), CE, TGA, and NMPA. As of January 2024, 510(k) was the most followed pathway for pipeline products in the market.

IVCF Pipeline Market Analysis by Regulatory Paths, 2024 (%)
IVCF Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the IVCF Pipeline Market
Download a Free Report Sample

IVCF Pipeline Market – Competitive Landscape

A few of the key companies associated with the IVCF pipeline market are Adient Medical Inc., APT Medical Inc., Contego Medical LLC, CyndRX LLC, and Interventional & Surgical Innovations, LLC among others.

Contego Medical LLC: Contego is headquartered in Raleigh, North Carolina, the US. The company focuses on the development of embolic protection devices for the treatment of cardiovascular and peripheral vascular procedures. Its integrated embolic protection (IEP) platform is designed such that embolization is suitable for all angioplasty and stenting procedures in vascular beds such as carotid, peripheral, and coronary arteries. The company markets its products in European Markets.

Interventional & Surgical Innovations (ISI), LLC: ISI is headquartered in New York, the US. It is a medical device company engaged in developing products for the cardiovascular market. The company enters into strategic partnerships with various other companies to develop new products and commercialize the existing products. It has an agreement with Dr. Juan Parodi to develop and commercialize its proprietary guidewire platform technology for minimally invasive interventional surgical procedures.

IVCF Pipeline Market Analysis by Companies, 2024
IVCF Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the IVCF Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

IVCF Pipeline Market Segments Outlook

  • Retrievable IVCF
  • Permanent IVCF
  • IVCF Retrieval Devices

IVCF Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Global
  • New Zealand

IVCF Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • TGA
  • NMPA

Scope

This report provides:

  • Extensive coverage of the IVCF under development.

  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of IVCF and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of IVCF under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Adient Medical Inc.
APT Medical Inc
Contego Medical LLC
CyndRX LLC
Interventional & Surgical Innovations, LLC
Kaleidoscope
Koninklijke Philips NV
Suzhou Tianhong Shengjie Medical Co Ltd
University of Arizona
University of Toledo
Veniti Inc
VueKlar Cardiovascular Ltd (Inactive)
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Inferior Vena Cava Filters (IVCF) Overview

  • 3 Products under Development

    • 3.1 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development

    • 3.2 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Segment

    • 3.3 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Territory

    • 3.4 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Regulatory Path

    • 3.5 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Estimated Approval Date

    • 3.6 Inferior Vena Cava Filters (IVCF) – Ongoing Clinical Trials

  • 4 Inferior Vena Cava Filters (IVCF) – Pipeline Products under Development by Companies

    • 4.1 Inferior Vena Cava Filters (IVCF) Companies – Pipeline Products by Stage of Development

    • 4.2 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development

  • 5 Inferior Vena Cava Filters (IVCF) Companies and Product Overview

    • 5.1 Adient Medical Inc. Company Overview

      • 5.1.1 Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 APT Medical Inc Company Overview

      • 5.2.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Contego Medical LLC Company Overview

      • 5.3.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 CyndRX LLC Company Overview

      • 5.4.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Interventional & Surgical Innovations, LLC Company Overview

      • 5.5.1 Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Kaleidoscope Company Overview

      • 5.6.1 Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Koninklijke Philips NV Company Overview

      • 5.7.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview

      • 5.8.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 University of Arizona Company Overview

      • 5.9.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 University of Toledo Company Overview

      • 5.10.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Veniti Inc Company Overview

      • 5.11.1 Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 VueKlar Cardiovascular Ltd (Inactive) Company Overview

      • 5.12.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

      • 5.13.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Inferior Vena Cava Filters (IVCF)- Recent Developments

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

Table

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development 9

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Segment 10

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Territory 11

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Regulatory Path 12

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Estimated Approval Date 13

Inferior Vena Cava Filters (IVCF) – Ongoing Clinical Trials 14

Inferior Vena Cava Filters (IVCF) Companies – Pipeline Products by Stage of Development 15

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development 16

Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

Absorbable Vascular Filter – Product Status 17

Absorbable Vascular Filter – Product Description 17

Adient Medical Inc. – Ongoing Clinical Trials Overview 18

Absorbable Vascular Filter – A Prospective, Multicenter, Pivotal Study with Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Vena Cava Filter for Pulmonary Embolism Prevention 19

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Retrievable Inferior Vena Cava Filter – Product Status 20

Retrievable Inferior Vena Cava Filter – Product Description 20

Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Temporary IVC Filter – Product Status 21

Temporary IVC Filter – Product Description 21

CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview 22

Inferior Vena Cava (IVC) Filter – Product Status 22

Inferior Vena Cava (IVC) Filter – Product Description 22

Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Inferior Vena Cava Filter – Product Status 23

Inferior Vena Cava Filter – Product Description 23

Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview 24

Reversible IVC Filter – Product Status 24

Reversible IVC Filter – Product Description 24

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 25

LUMIFI with Crux VCF System – Product Status 25

LUMIFI with Crux VCF System – Product Description 25

Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

Vena Cava Filter – Product Status 26

Vena Cava Filter – Product Description 26

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 27

Inferior Vena Cava Filter – Product Status 27

Inferior Vena Cava Filter – Product Description 27

University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 28

IVC Filter Retrieval System – Product Status 28

IVC Filter Retrieval System – Product Description 28

Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview 29

VENITI VIDI Vena Cava Filter – Product Status 29

VENITI VIDI Vena Cava Filter – Product Description 29

VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

MR-Enhancing Retrievable Vena Cava Filter – Product Status 30

MR-Enhancing Retrievable Vena Cava Filter – Product Description 30

Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Implantable Inferior Vena Cava Filter – Product Status 31

Implantable Inferior Vena Cava Filter – Product Description 31

Zylox-Tonbridge Medical Technology Co Ltd – Ongoing Clinical Trials Overview 32

Implantable Inferior Vena Cava Filter – Multi-center, Randomized and Non-inferiority Clinical Trial to Investigate the Efficacy and Safety of Retrievable Inferior Vena Cava Filter 33

Glossary 40

Figures

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development 9

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Segment 10

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Territory 11

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Regulatory Path 12

Inferior Vena Cava Filters (IVCF) – Pipeline Products by Estimated Approval Date 13

Inferior Vena Cava Filters (IVCF) – Ongoing Clinical Trials 14

Frequently asked questions

Inferior Vena Cava Filters (IVCF) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Inferior Vena Cava Filters (IVCF) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Inferior Vena Cava Filters (IVCF) reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Inferior Vena Cava Filters (IVCF) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Inferior Vena Cava Filters (IVCF) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more